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0883-9441/© 2019 Elsevier Inc. All rights reserved.a b s t r a c ta r t i c l e i n f oPurpose: To study mortality in severe acute pancreatitis (SAP) and to identify risk factors for mortality.
Materials andmethods: A retrospective 17-years' cohort study of 435 consecutive adult patients with SAP treatedKeywords:at intensive care unit of a university hospital.
Results: Overall, 357 (82.1%) patients survived at 90 days follow-up. Three-hundred six (89.5%) patients under
60 years, 38 (60.3%) patients between 60 and 69 years, and 13 (43.3%) patients over 69 years of age survived
at 90 days follow-up. Independent risk factors for death within 90-days were: 60 to 69 years of age (odds ratio
[OR] 5.1), N69 years of age (OR 10.4), female sex (OR 2.0), heart disease (OR 2.9), chronic liver failure (OR
12.3), open abdomen treatment (OR 4.4) and sterile necrosectomy within 4 weeks (OR 14.7). The 10-year sur-
vival estimate was b70% in patients under 60 years and b30% in patients over 60 years. Underlying cause of
death after the initial 90-day follow-upperiodwas alcohol-related in 48 (57.1%) patients, and all of themhad suf-
fered from alcoholic SAP.
Conclusions: Although younger patients have excellent short-term survival after SAP, the long-term survival es-
timate is disappointing mostly due to alcohol abuse.
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The definition of severe acute pancreatitis (SAP) according to the re-
vised Atlanta classification (2012) is organ failure (OF) affecting respira-
tory, renal or cardiovascular system, that does not resolve within 48 h
[1]. Severe acute pancreatitis occurs in about 10% of patients with
acute pancreatitis [2,3]. Patients with SAP usually require admission to
intensive care unit (ICU), where treatment may last for several weeks
[3,4]. Management of patients with SAP is supportive, including renal
replacement therapy, mechanical ventilation and inotropic medication
[1]. Early enteral nutrition is associated with fewer local and distant in-
fectious complications, seems to reducemortality, and is recommended
to be started routinely in the management of SAP [5,6]. Managing
secondary infections plays an important part of treatment, and somepa-
tientsmay need surgical treatment for complications such as abdominal
compartment syndrome (ACS) or infected pancreatic necrosis (IPN)
[7-10]. However, necrosectomy should be postponed to after 4 weeks
from symptom start whenever possible [6].
The mortality rate in acute pancreatitis (AP) is about 2.7–7.5%, and
increasing age is associated with increased mortality [3,11,12]. Aboutal Surgery, Helsinki University50% of deaths occur within the first 2 weeks of the disease and early
death is usually associated with persistent multiple organ failure
(MOF) [11-13]. Organ failure in AP is associated with up to 30%mortal-
ity rates [14]. Type 2 diabetes and fatty liver might increase mortality in
AP, but to our knowledge there are few studies on the effect of pre-
existing comorbidities onmortality using the latest classification system
of the severity of acute pancreatitis [15,16]. Furthermore, there is lim-
ited information regarding short- and long-term mortality in SAP
based on the new classification system.
Severe acute pancreatitis increases the risk for intra-abdominal hy-
pertension and ultimately ACS and a recent systematic review reported
as high as 49%mortality rates in patients with ACS related to AP [17-21].
Conservative management of intra-abdominal hypertension consists of
optimized fluid management, sedation and analgesia, neuromuscular
blockade and evacuation of intraluminal contents and intra-abdominal
collections [22]. Abdominal compartment syndrome requiring surgical
decompression is associated with severe MOF and high mortality and
morbidity rates [8]. Infected pancreatic necrosis is associated withmor-
tality and delaying necrosectomy for IPN, has previously been shown to
have survival benefit [14,23]. Current guidelines recommend delaying
invasive interventions (i.e. endoscopic transluminal drainage or
necrosectomy, minimally invasive or open necrosectomy) whenever
possible for 4 weeks after onset of symptoms for the collections to be-
come walled off [6].
Table 1
Patient Characteristics.
Age, median (IQR), y 48 (39–58)
Duration of symptoms before hospital admission, median (IQR), d 1 (0–1)
Hospital length of stay before ICU admission, median (IQR), d 1 (1–3)
Intensive care unit length of stay, median (IQR), d 13 (6–25)
Hospital length of stay, median (IQR), d 25 (15–45)
Sex, n (%)
Female 80 (18.4)
Male 335 (81.6)
Etiology, n (%)
Alcohol 335 (77.0)
Biliary 51 (11.7)
Other 49 (11.3)
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in patients with SAP according to the revised Atlanta classification
(2012). In addition, the aim is to evaluate the impact of pre-existing co-
morbidities, disease complications and treatment strategies on survival
in a large cohort of patients from a single center. The impact of changes
in treatment protocols on survival is also reported.
2. Material and methods
This is a retrospective analysis of patients with SAP treated at some
point of the disease in the ICU at the Helsinki University Hospital
(HUH) Meilahti between January 1, 1999 and December 31, 2015. Infor-
mation was gathered from hospital records including daily ICU-
monitoring sheets. The diagnostic criteria for pancreatitis included
typical abdominal pain and serum amylase level at least three times the
upper limit of normal or pancreatitis verified on CT-scan. Severe acute
pancreatitis was defined by persistent organ failure not resolving within
the first 48 h according to revised Atlanta classification (2012) [1]. Short-
and long-term information on survival was collected from the Finnish
civil registry records. Cause of death was gathered from hospital records,
and if cause of death was not retrievable from hospital records it was
gathered from Statistics Finland (http://www.stat.fi). STROBE statement
checklist (http://www.strobe-statement.org) was followed.
Meilahti Hospital serves as the secondary and tertiary surgical refer-
ral center in the area with a catchment population of about 1.4 million.
The majority of patients with SAP are treated in the ICU of the Meilahti
Hospital, the largest ICU in the area. The initial search in patient data-
base included all patients treated at ICUduring the study periodwith di-
agnosis of acute pancreatitis (n = 610). Data of these 610 patients was
systematically reviewed to identify those patients that fulfilled the re-
vised Atlanta classification (2012) criteria for SAP. One-hundred
seventy-two patients were excluded from this study because they did
not meet the criteria for SAP. Furthermore, three patients were lost to
follow up, and consequently these patients were excluded from this
study. This resulted in 435 patients meeting the inclusion criteria. Data
of surgical necrosectomies were gathered. Indication for surgical
necrosectomy was clinical suspicion or verified infected necrosis. An-
other indication was persistent symptoms due to walled off necrosis
without suspicion of infection later than four weeks from symptom
onset. Patients were divided into two groups based on the period of
treatment (group 1, n = 204: 1999–2007 and group 2, n = 231:
2008–2015) to evaluate potential differences in survival and the effect
of changes in management strategies.
2.1. Statistical analysis
A Kaplan-Meier analysis on survival at 90 days and for the total
follow-up time was performed, and survival differences were statisti-
cally compared using Log Rank test. Univariate odds ratios with 95%
confidence intervals were calculated to identify patient-, disease-, and
treatment-related variables affecting survival. All statistically significant
univariate analysis results, and other clinically relevant variables were
included in a multivariate logistic regression analysis. Differences re-
garding continuous variables were analysed with Mann-Whitney U
test. Pearson Chi-Square test or Fisher's Exact Test (2-sided) (when
comparing sample sizes equal or b5) were used in comparison of pro-
portions. All statistical analysis was made with SPSS 24.0 (IBM Corp.,
Armonk, NY, USA).
3. Results
3.1. Patient data and characteristics
Patient characteristics are presented in Table 1. Overall, female pa-
tients in this study were significantly older (P = .002) than male pa-
tients, and the median age at disease onset was 54 years (interquartilerange [IQR], 44–64 years) for females and 47 years (IQR, 39–56 years)
for males, respectively. The etiology of pancreatitis differed significantly
between the sexes (P b .001): etiology of SAP in 39 (48.8%) female pa-
tients was other than alcohol, whereas 294 (82.8%) male patients suf-
fered from alcoholic SAP.
Three-hundred seven (70.6%) patients were managed
nonoperatively within the first 90 days; 68 (15.6%) patients required
open abdomen treatmentmostly due to ACS or to prevent ACS after lap-
arotomy, and 103 (23.7%) patients had open surgical necrosectomy.
During thewhole follow-up time 110 (25.3%) patients had open surgical
necrosectomy at some point of their illness.
3.2. 90-day (short-term) survival rate
Overall, 357 (82.1%) patients survived 90 days after hospital admis-
sion. Survivors were significantly younger, median 47 years (IQR,
39–55 years) than non-survivors 61 years (IQR, 44–68), P b .001. Under-
lying cause of deathwas acute pancreatitis in 77 (98.7%) patients within
90 days after hospital admission.
The impact of age on survival was evaluated by grouping patients by
age at disease onset (Fig. 1). We found, that 306 (89.5%) patients under
60 years of age, 38 (60.3%) patients between 60 and 69 years, and 13
(43.3%) patients aged 70 or more survived at 90-days follow-up
(Fig. 2). Patients under 60-years were subcategorized into three groups
(under 40 years, 40–49 years and 50–59 years), but there was no differ-
ence in 90-day (P = .844) between these groups. 98 (89.1%), 109
(90.8%) and 99 (88.4%) patients survived at 90 days follow-up,
respectively.
Univariate logistic regression analysis of risk factors for death within
90 days are summarized in Table 2. To consider potential confounding
factors, a multivariate logistic regression analysis based on results of
univariate analysis and other clinically relevant collected data was per-
formed. The results are summarized in Table 3.
3.3. Long-term survival
The median follow-up time of patients in this study was 5.8 years
(mean; 6.0 years, IQR; 1.1–9.5 years, range; 0–17.3 years). The long-
term survival estimate is presented in Fig. 3. The 10-year survival esti-
mate was 28.3% and 67.9% for patients over and under 60 years, respec-
tively. Survival estimates at 10 years after SAP in patients under 60-
years subcategorized into three groups (under 40 years, 40–49 years
and 50–59 years) were 65.7%, 68.4% and 69.5%, respectively (P =
.680). The median age at death was 38.1 years, 47.7 years and
56.2 years, respectively.
Underlying cause of death in patients that died after 90 days from
hospital admission was acute pancreatitis in 22 (26.2%). These late
deaths occurred due to alcohol-related reasons (any underlying, imme-
diate or contributory alcohol-related disease, alcohol-intoxication or
traumatic death related to alcohol-use) in 48 (57.1%) patients, and all
of these patients had suffered from alcoholic SAP, whereas alcohol-
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Fig. 1. Age and 90-day Survival.
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(P b .001).
3.4. Differences between group 1 (1999–2007, n = 231) and group 2
(2008–2015, n = 204)
In comparison to group 1 there were significantly more patients
with pre-existing diabetes and respiratory disease in group 2: 34
(16.7%) vs. 22 (9.5%), P = .026, and 26 (12.7%) vs. 16 (6.9%), P = .040,
respectively. There were no age (P = .291), sex (P = .062) or other
known significant differences between the groups.
In group 2 comparedwith group 1, open abdomenwas utilizedmore
frequently: 43 (21.1%) vs. 25 (10.8%) patients, P= .003.Within 90 days
from symptom start 54 (26.5%) and 49 (21.2%), P= .198, patients were
treatedwith surgical necrosectomy in group2 and group 1, respectively,
and the proportion of late (N4 weeks) necrosectomies increased signif-
icantly in group 2 21 (38.9%) vs. 9 (18.4%), P = .022. Additionally, in
group 2, the proportion of necrosectomies within 90 days due to sterileP < 0.001, Log Rank Test
0 days 20 days 40 days 60 days 80 days
< 60 years Patients at risk 342 327 316 310 306
60-69 years Patients at risk 63 50 44 42 40
≥ 70 years Patients at risk 30 20 15 13 13
Fig. 2. Kaplan-Meier 90-day Survival Table.necrosis decreased: 5 (9.3%) vs. 16 (32.7%) patients, P= .003. The over-
all number of patients requiring necrosectomies within 90 days due to
IPN increased in group 2 compared to group 1: 49 (24.0%) vs. 33
(14.3%), P = .010. Within the 90-day follow-up period 186 (80.5%)
and 171 (83.8%) patients survived during the years 1999–2007 and
2008–2015, respectively, but the difference was not statistically signifi-
cant (P = .373) (Fig. 4).
4. Discussion
This study with a long follow-up time in a large cohort of patients
treated in an ICU with SAP demonstrates that patients under 60 years
with SAP have excellent 90-day survival. Age had a major impact on
90-day survival even after adjusting for pre-existing co-morbidities,
resulting in poor outcome in elderly patients. The majority of patients
were managed nonoperatively. Surgical decompression for ACS and
necrosectomy for sterile necrosis within the first 4 weeks were associ-
ated with increased risk of death within the first 90 days.
Ninety-day survival worsened significantly if patients were over
60-years of age, and survival was even worse in patients over 70-years
of age. Our results on the impact of age on survival in SAP are in line
with previous results concerning AP [7,11]. Heart disease, including cor-
onary artery disease and cardiac insufficiency, and chronic liver failure
worsen survival in SAP. A previous study suggests that diabetes might
increasemortality in AP, but our study failed to show a significant effect
of diabetes on outcome in SAP [15]. Even if the number of patients in
this study was relatively large, the prevalence of some pre-existing co-
morbiditieswas fairly low,making definite conclusions on other comor-
bidities' effect on survival in SAP difficult.
In multivariate analysis, female sex was associated with reduced
90-day survival. Intriguingly, female sex was a predictor of mortality
in a previous cohort study on open surgical debridement of pancreatic
necrosis [9]. Even so, our result may also reflect the two major differ-
ences between female and male patients in this cohort: female patients
were in general significantly older and alcohol etiologywas significantly
less frequent in comparison with male patients. Also, during this
17-year study period, only 80 female patients met the inclusion criteria
for this study, and this relatively low number of female patients might
have influenced the results.
Open abdomen treatment, that is used mostly to reduce intra-
abdominal pressure in ACS or to prevent occurrence of ACS after
laparotomy, was associated with worse 90-day survival in our study.
An earlier study fromour institution showed that patients requiring sur-
gical decompression for ACS suffer fromMOF, with amedian Sequential
Table 2
90-day survival univariate analysis.
Risk factor Non-survivors⁎ Survivors⁎ All patients† Odds ratio (95% CI) P
Sex
Female 20 (25.0) 60 (75.0) 80 (18.4) 1.707 (0.957–3.046) 0.070
Male 58 (16.3) 297 (83.7) 355 (81.6) 0.586 (0.328–1.045) 0.070
Age, y
b60 36 (10.5) 306 (89.5) 342 (78.6) reference b0.001
60–69 25 (39.7) 38 (60.3) 63 (14.5) 5.592 (3.034–10.308) b0.001
≥70 17 (56.7) 13 (43.3) 30 (6.9) 11.115 (4.992–24.749) b0.001
Etiology
Alcohol 47 (14.0) 288 (86.0) 335 (77.0) reference 0.001
Biliary 17 (33.3) 34 (66.7) 51 (11.7) 3.064 (1.585–5.921) 0.001
Other 14 (28.6) 35 (71.4) 49 (11.3) 2.451 (1.227–4.898) 0.011
Comorbidities
None 36 (12.4) 254 (87.6) 290 (66.7) 0.348 (0.211–0.573) b0.001
Diabetes 17 (30.4) 39 (69.6) 56 (12.9) 2.272 (1.208–4.276) 0.011
Chronic pancreatitis 6 (23.1) 20 (76.9) 26 (6.0) 1.404 (0.545–3.620) 0.482
Heart disease 27 (40.9) 39 (59.1) 66 (15.2) 4.317 (2.434–7.655) b0.001
Renal disease 5 (35.7) 9 (64.3) 14 (3.2) 2.648 (0.862–8.133) 0.089
Pulmonary disease 10 (23.8) 32 (76.2) 42 (9.7) 1.494 (0.701–3.183) 0.299
Chronic liver failure 5 (71.4) 2 (28.6) 7 (1.6) 12.158 (2.314–63.880) 0.003
Previous pancreatitis
None 65 (19.3) 271 (80.7) 336 (77.2) reference 0.368
Once 8 (13.6) 51 (86.4) 59 (13.6) 0.654 (0.296–1.445) 0.294
Twice or more 5 (12.5) 35 (87.5) 40 (9.2) 0.596 (0.225–1.580) 0.298
Infected pancreatic necrosis 22 (21.4) 81 (78.6) 103 (23.7) 1.339 (0.771–2.325) 0.300
Other infection 44 (18.6) 193 (81.4) 237 (54.5) 1.100 (0.671–1.801) 0.706
Group
1999–2007 45 (19.5) 186 (80.5) 231 (53.1) 1.254 (0.764–2.056) 0.371
2008–2015 33 (16.2) 171 (83.8) 204 (46.9) 0.798 (0.486–1.308) 0.371
Non-operative management 43 (14.0) 264 (86.0) 307 (70.6) 0.433 (0.261–0.717) 0.001
Open abdomen 24 (35.3) 44 (64.7) 68 (15.6) 3.162 (1.779–5.619) b0.001
Necrosectomy ≤ 90 days‡
No necrosectomy 51 (15.4) 281 (84.6) 332 (76.3) reference b0.001
Sterile necrosis 11 (52.4) 10 (47.6) 21 (4.8) 6.061 (2.447–15.009) b0.001
Infected necrosis 16 (19.5) 66 (80.5) 82 (18.9) 1.336 (0.717–2.489) 0.362
Necrosectomy ≤ 4 weeks‡
No necrosectomy 51 (15.4) 281 (84.6) 332 (76.3) reference 0.001
Necrosectomy on day 0–28 24 (32.9) 49 (67.1) 73 (16.8) 2.699 (1.523–4.783) 0.001
Necrosectomy on day 29–90 3 (10.0) 27 (90.0) 30 (6.9) 0.612 (0.179–2.094) 0.434
Timing of necrosectomy‡
No necrosectomy 51 (15.4) 281 (84.6) 332 (76.3) reference b0.001
≤4 wk, sterile necrosis 11 (64.7) 6 (35.3) 17 (3.9) 10.101 (3.576–28.536) b0.001
≤4 wk, infected necrosis 13 (23.2) 43 (76.8) 56 (12.9) 1.666 (0.837–3.316) 0.146
N4 wk, sterile necrosis 0 (0.0) 4 (100.0) 4 (0.9) 0.000 (0.000 - NC) 0.999
N4 wk, infected necrosis 3 (11.5) 23 (88.5) 26 (6.0) 0.719 (0.208–2.482) 0.601
CI = confidence interval, NC = not countable.
⁎ Unless otherwise noted, data is presented as number of patients (% in subgroup of patients with the comorbidity in question).
† Number of patients (% of total number of patients, n = 435).
‡ Timing of necrosectomy from the start of symptoms.
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sion, and hence the disease itself might be the reason for poor survival
despite surgical efforts [8,21]. Surgical management of ACS isTable 3
90-day Survival, Multivariate Analysis.
Risk factor Odds ratio (95% CI) P
Age, y
b60 reference b0.001
60–69 5.095 (2.452–10.588) b0.001
≥70 10.366 (4.105–26.174) b0.001
Female sex 2.023 (1.005–4.072) 0.048
Heart disease 2.858 (1.395–5.853) 0.004
Chronic liver failure 12.305 (1.747–86.654) 0.012
Open abdomen 4.413 (2.018–9.650) b0.001
Necrosectomy
No necrosectomy reference b0.001
Necrosectomy ≤ 4 wk, sterile 14.658 (4.402–48.804) b0.001
Necrosectomy ≤ 4 wk, infected 1.493 (0.614–3.626) 0.376
Necrosectomy N 4 wk⁎ 0.382 (0.093–1.575) 0.183
⁎ Necrosectomy due to sterile or infected pancreatic necrosis, and timing of
necrosectomy (earlier or later than 4weeks after onset) were evaluated using a single var-
iable due to otherwise presented redundancies in the equation. CI = confidence interval.considered a life-saving operation, although the scientific evidence to
support this in patientswith SAP is limited [24]. BecauseACS usually de-
velops early in the course of SAP, a reduction of earlymortalitywould be
expected if ACS is managed surgically in a timely manner. However, no
such reduction of early or late mortality was observed in this study, al-
though surgicalmanagement of ACSwith open abdomenbecame signif-
icantly more frequent during latter years of study. Therefore, this study
doesn't provide additional information into which patients benefit from
surgical open abdomen treatment of ACS in SAP, and further study is
needed in this area.
Necrosectomies in the present series were done using the anterior
open surgical debridement approach. The indication for necrosectomy
was either clinical suspicion of infected necrosis or verified infected ne-
crosis. Only a minority of all patients 103 (23.7%) had necrosectomy
within 90 days. In 21 (20.4%) patients infection could not be verified.
In line with previously reported results, our data showed that
necrosectomy within the first 4 weeks of disease due to sterile necrosis
is associated with worse survival [9]. These patients usually present
with progressive MOF after the second week, and if worsening is not
due to infected necrosis, surgery with high risk of bleeding may be det-
rimental to the patient. On the other hand, early necrosectomy (within
P < 0.001, Log Rank Test
0 years 5 years 10 years 15 years
< 60 years Patients at risk 342 213 81 17
60-69 years Patients at risk 63 22 8 0
≥ 70 years Patients at risk 30 6 1 0
Fig. 3. Kaplan-Meier Long-time Survival Estimate.
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survival. Furthermore, late necrosectomy (after 4 weeks) regardless of
the infection of necrosis did not influence survival. Therefore, it seems
very important to determine the possible presence of infected necrosis
before surgical intervention, unless intervention is postponed until
four weeks has passed from the disease onset. Earlier studies have
shown that preoperative verification of IPN (fine-needle aspiration
and culture or gas-filled collection on CT-scan) is insufficient, and con-
sequently the diagnostic workup remains a clinical challenge [9]. AP = 0.373, Log Rank Test
0 days 20 days 40 days 60 days 80 days 
1999-2007 Patients at risk 231 209 195 190 186 
Group1 
2008-2015 Patients at risk 204 188 180 175 173 
Group2 
Fig. 4. Kaplan-Meier 90-day Survival Group 1 vs Group 2.step-up percutaneous drainage with bacterial cultures serves as a
method of choice during the first four weeks. During the later study pe-
riod in this series, fewer patients with sterile necrosis were operated on,
which could reflect the change in the diagnostic workup for suspected
infected necrosis.
The survival rate after late open necrosectomy was 90%, which is
comparable to survival after mini-invasive necrosectomies for walled
off necrosis [25-28]. Interestingly, all four patients undergoing late
necrosectomy due to sterile pancreatic necrosis survived. Although
this scenario is quite rare, the result might indicate that late operative
treatment of walled off sterile necrosis can be a safe and feasible option
in those patients suffering from symptomatic sterile necrosis after SAP,
but further study is needed.
A recent Finnish study in working-age patients, where criteria for
SAP might have included some patients with moderately severe acute
pancreatitis according to the latest Atlanta classification, showed a
10-year survival estimate of 60% in patients with SAP [29]. In line with
these findings, our results in a large cohort of patients treated at ICU
with SAP according to the latest Atlanta classification showed a long-
time survival of b70% in patients younger than 60 years. Early in the
acute course of the disease, significant management resources are
invested in these patients, resulting in good primary outcome as
shown in this study [4]. However, these significant efforts do not
translate into good long-term survival, and our results indicate that
ongoing excessive alcohol consumption contributes to shortened life-
expectancy in younger patients with SAP. This finding warrants that
the medical profession increases their involvement in prevention of al-
cohol abuse in patients surviving from alcoholic SAP short-termly.
Recent years' changes in the recommendations for themanagement
of SAP were reflected in this study. A shift towards later necrosectomy
was observed, and during later years most necrosectomies were done
due to infection. In addition, open abdomen treatment became a more
common practice during the latter years. Despite these changes in the
management the survival did not improve significantly.
One of the limitations of this study is that an index reflecting
disease-severity, such as the Sepsis-related Organ Failure Assessment
score (SOFA), was not collected from the cohort of patients. Hence,
the analysis was not assessed in relation to disease severity or organ-
specific failures. Another limitation of study is the retrospective setting,
where the patient material itself might have changed during the years,
which may reduce the value of the assessment of changes in the treat-
ment. Therefore, it is possible that the spectrum of the disease could
have introduced a bias to the results. Also, in contrast to most studies
on SAP where biliary etiology is more common than alcohol, the main
etiology of SAP in this cohort was alcohol. This difference could mean
that the long-term survival resultsmay not be comparable with etiolog-
ically differing cohorts. Also, the management of elderly patients with
anticipated poor outcome might have been different from younger
patients, which could have affected age-related survival differences.
Furthermore, although long-term survival records were reported, we
did not investigate the quality of life in patients that survived.5. Conclusions
Severe acute pancreatitis can be managed with excellent 90-day
survival rate in young and otherwise healthy patients. The majority of
patients can be managed non-operatively, which results in excellent
short-term survival. Open abdomen treatment and necrosectomywith-
out actual infection within the first 4 weeks of the disease increase the
risk of death. The overall survival rate did not change significantly dur-
ing the study period despite significant changes in indications and
timing of surgery. However, the long-term survival estimate is disap-
pointing even in younger patients. Predominantly alcoholic etiology of
pancreatitis in younger patients associated with alcohol related death
and short life expectancy. Results indicate that successful prevention
86 H.L. Husu et al. / Journal of Critical Care 53 (2019) 81–86of ongoing alcoholic abuse in patients that survive alcoholic SAP could
increase their long-term survival.
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